Comprehensive Genomic Profiling (CGP) of clinical T2-4N0M0 Muscle-Invasive Bladder Cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatin-based chemotherapy before Radical Cystectomy (RC)
European Urology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要